Cationic lipids are essential for gene delivery mediated by intravenous administration of lipoplexes
- PMID: 10455423
- DOI: 10.1038/sj.gt.3300929
Cationic lipids are essential for gene delivery mediated by intravenous administration of lipoplexes
Abstract
It was recently suggested that intravenously administered lipoplexes serve as a depot for the extracellular release of naked DNA and it is the naked DNA that mediates gene delivery in the lung. If this is the mechanism responsible for gene expression, we reasoned that continuous infusion of plasmid DNA should also result in significant lung expression in the absence of lipoplexes. Moreover, the infusion of non-coding plasmid DNA should inhibit gene delivery by lipoplexes. Infusion of plasmid DNA at a rate of 80 microg/min into the tail vein of a mouse resulted in a DNA serum concentration of 800 microg/ml. This was equivalent to a transcriptionally active DNA concentration of 120 microg/ml plasma as determined by an in vitro transfection assay. In spite of this high level of transcriptionally active DNA, there was no significant gene expression in the lung or any other organ tested. In addition, when lipoplex containing a reporter gene was injected, followed by an infusion of non-coding plasmid DNA as a potential competing molecule for DNA released from the lipoplex there was no effect on gene expression. These experiments indicate that the cationic lipid component of the lipoplex functions in an active capacity beyond that of a simple passive release matrix for plasmid DNA.
Similar articles
-
Improved in vitro gene transfer mediated by fluorinated lipoplexes in the presence of a bile salt surfactant.J Gene Med. 2001 Jul-Aug;3(4):338-44. doi: 10.1002/jgm.188. J Gene Med. 2001. PMID: 11529663
-
Interaction of bronchoalveolar lavage fluid with polyplexes and lipoplexes: analysing the role of proteins and glycoproteins.J Gene Med. 2003 Jan;5(1):49-60. doi: 10.1002/jgm.291. J Gene Med. 2003. PMID: 12516051
-
Enhanced in vitro and in vivo cationic lipid-mediated gene delivery with a fluorinated glycerophosphoethanolamine helper lipid.J Gene Med. 2001 Mar-Apr;3(2):109-14. doi: 10.1002/jgm.166. J Gene Med. 2001. PMID: 11318109
-
The mechanism of naked DNA uptake and expression.Adv Genet. 2005;54:3-20. doi: 10.1016/S0065-2660(05)54001-X. Adv Genet. 2005. PMID: 16096005 Review.
-
Physicochemical optimisation of plasmid delivery by cationic lipids.J Gene Med. 2004 Feb;6 Suppl 1:S24-35. doi: 10.1002/jgm.509. J Gene Med. 2004. PMID: 14978748 Review.
Cited by
-
The Trojan Horse Liposome Technology for Nonviral Gene Transfer across the Blood-Brain Barrier.J Drug Deliv. 2011;2011:296151. doi: 10.1155/2011/296151. Epub 2011 Nov 16. J Drug Deliv. 2011. PMID: 22175028 Free PMC article.
-
Gene Therapy for Acute Respiratory Distress Syndrome.Front Physiol. 2022 Jan 17;12:786255. doi: 10.3389/fphys.2021.786255. eCollection 2021. Front Physiol. 2022. PMID: 35111077 Free PMC article. Review.
-
Brain gene therapy with Trojan horse lipid nanoparticles.Trends Mol Med. 2023 May;29(5):343-353. doi: 10.1016/j.molmed.2023.02.004. Epub 2023 Mar 11. Trends Mol Med. 2023. PMID: 36907687 Free PMC article. Review.
-
Blood-brain barrier transport of non-viral gene and RNAi therapeutics.Pharm Res. 2007 Sep;24(9):1772-87. doi: 10.1007/s11095-007-9321-5. Epub 2007 Jun 8. Pharm Res. 2007. PMID: 17554608 Review.
-
An amino acid-based amphoteric liposomal delivery system for systemic administration of siRNA.Mol Ther. 2011 Jun;19(6):1141-51. doi: 10.1038/mt.2011.56. Epub 2011 Apr 19. Mol Ther. 2011. PMID: 21505423 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources